Articles published by Mirum Pharmaceuticals, Inc.
![](https://mms.businesswire.com/media/20240116855446/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20240110385826/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 10, 2024
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20240108332335/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
January 08, 2024
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20240103985129/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231218379840/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Announces Data from EMBARK Phase 2b Study for Biliary Atresia
December 18, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231208048015/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 08, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231120253689/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231113329951/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Presents New Data at The Liver Meeting®
November 13, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231110593151/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231103747669/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals to Present at the 2023 UBS Biopharma Conference
November 03, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231102727938/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231030353736/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals to Present New Data at The Liver Meeting®
October 30, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231026226565/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20231017111211/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20231010177957/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231007605416/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN
October 07, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20231002522656/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20230926619683/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals to Highlight LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
September 26, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230921485255/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230911956575/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Announces the Appointment of Eric Bjerkholt as Chief Financial Officer
September 11, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230908842368/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 08, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230906262513/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
September 06, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230905204912/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20230810997794/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 10, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230803986457/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Mirum Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
August 03, 2023
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230727925918/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20230717969028/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
![](https://mms.businesswire.com/media/20230710178616/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Via Business Wire
Tickers
MIRM
![](https://mms.businesswire.com/media/20230623469300/en/746217/5/Mirum_Inline_FullColor_RGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.